JUM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giorgio, A.
Right arrow Articles by Aloisio, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giorgio, A.
Right arrow Articles by Aloisio, T.

Journal of Ultrasound in Medicine, Vol 11, Issue 11 587-595, Copyright © 1992 by American Institute of Ultrasound in Medicine

JOURNAL ARTICLE

Percutaneous ethanol injection under sonographic guidance of hepatocellular carcinoma in compensated and decompensated cirrhotic patients

A. Giorgio, L. Tarantino, G. Francica, V. Scala, N. Mariniello and T. Aloisio
Quinta Divisione Ospedale D. Cotugno, Scuola S.I.U.M.B. Di Ecointerventistica, Napoli, Italy.

Forty-six patients with cirrhosis and 75 biopsy-proved hepatocellular carcinoma (HCC) nodules underwent percutaneous ethanol injection (PEI) regardless of number (up to five) and size (mean diameter, 3.6 cm) of tumoral lesions and clinical severity of cirrhosis (11 patients in Child's class C were included). Ethanol was injected under sonographic guidance through 20 to 22 gauge needles so as to obtain homogeneous hyperechogenicity of lesions. A total of 271 PEI sessions were carried out, delivering 2 to 14 ml per session. All nodules but one decreased in size, and seven were no longer appreciable on sonography. Recurrence was detected in two patients. The 3 year survival rate of all cases was 86%. Child's classes A and B patients fared better (3 yr survival 100%); 2 year survival of subjects with HCC < or = 3 cm was 92%. Multifocality did not affect survival. Most patients experienced mild pain at the site of injection, but only two major complications were encountered: partial chemical thrombosis of the left portal vein and cholangitis. Both cases were managed conservatively. In conclusion, PEI seems to offer a safe and valuable tool for therapy of HCC, especially in patients with good functional liver reserve and small (< or = 3 cm) tumors.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
A. Giorgio, L. Tarantino, G. de Stefano, V. Scala, G. Liorre, F. Scarano, A. Perrotta, N. Farella, V. Aloisio, N. Mariniello, et al.
Percutaneous Sonographically Guided Saline-Enhanced Radiofrequency Ablation of Hepatocellular Carcinoma
Am. J. Roentgenol., August 1, 2003; 181(2): 479 - 484.
[Abstract] [Full Text] [PDF]

Home page
 J Ultrasound MedHome page
A. Giorgio, L. Tarantino, G. de Stefano, G. Francica, F. Esposito, A. Perrotta, V. Aloisio, N. Farella, N. Mariniello, C. Coppola, et al.
Complications After Interventional Sonography of Focal Liver Lesions: A 22-Year Single-Center Experience
J. Ultrasound Med., February 1, 2003; 22(2): 193 - 205.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
L. Tarantino, A. Giorgio, N. Mariniello, G. de Stefano, A. Perrotta, V. Aloisio, S. Tamasi, M. C. Forestieri, F. Esposito, L. Finizia, et al.
Percutaneous Ethanol Injection of Large Autonomous Hyperfunctioning Thyroid Nodules1
Radiology, January 1, 2000; 214(1): 143 - 148.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Institute of Ultrasound in Medicine.